Most Prescribed Drugs in England — NHS Prescribing Data — Page 4
Showing 91-120 of 2,661
| # | Drug | Category | Items | NHS Cost | Practices |
|---|---|---|---|---|---|
| 91 | Hydroxocobalamin | Nutrition and Blood | 3.2M | £9.3M | 6,693 |
| 92 | Levetiracetam | Central Nervous System | 3.2M | £32.3M | 6,994 |
| 93 | Warfarin sodium | Cardiovascular System | 3.1M | £6.4M | 6,527 |
| 94 | Betamethasone valerate | Skin | 3.0M | £15.4M | 7,717 |
| 95 | Mometasone furoate | Ear, Nose and Oropharynx | 2.9M | £25.2M | 7,346 |
| 96 | Progesterone | Endocrine System | 2.9M | £41.7M | 6,839 |
| 97 | Esomeprazole | Gastro-Intestinal System | 2.8M | £10.8M | 6,996 |
| 98 | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2.8M | £10.6M | 7,044 |
| 99 | Mirabegron | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2.8M | £71.5M | 6,887 |
| 100 | Linagliptin | Endocrine System | 2.7M | £78.4M | 6,651 |
| 101 | Docusate sodium | Gastro-Intestinal System | 2.7M | £17.3M | 7,315 |
| 102 | Fluticasone propionate (Inhalation) | Respiratory System | 2.7M | £77.1M | 6,993 |
| 103 | Buprenorphine | Central Nervous System | 2.7M | £47.6M | 7,312 |
| 104 | Promethazine hydrochloride | Respiratory System | 2.7M | £12.8M | 7,451 |
| 105 | Insulin aspart | Endocrine System | 2.6M | £111.5M | 6,931 |
| 106 | Sitagliptin | Endocrine System | 2.6M | £5.7M | 6,707 |
| 107 | Olanzapine | Central Nervous System | 2.6M | £8.3M | 7,038 |
| 108 | Digoxin | Cardiovascular System | 2.6M | £5.0M | 6,740 |
| 109 | Diclofenac diethyl | Musculoskeletal and Joint Diseases | 2.5M | £19.8M | 7,176 |
| 110 | Sumatriptan succinate | Central Nervous System | 2.5M | £24.3M | 7,108 |
| 111 | Lactulose | Gastro-Intestinal System | 2.5M | £13.2M | 7,498 |
| 112 | Melatonin | Central Nervous System | 2.4M | £45.3M | 7,216 |
| 113 | Cyanocobalamin | Nutrition and Blood | 2.4M | £12.8M | 6,714 |
| 114 | Estradiol with progestogen | Endocrine System | 2.3M | £69.8M | 6,843 |
| 115 | Phenoxymethylpenicillin (Penicillin V) | Infections | 2.3M | £8.6M | 7,553 |
| 116 | Mebeverine hydrochloride | Gastro-Intestinal System | 2.2M | £10.5M | 7,175 |
| 117 | Sodium valproate | Central Nervous System | 2.2M | £31.4M | 6,791 |
| 118 | Memantine hydrochloride | Central Nervous System | 2.2M | £9.5M | 6,531 |
| 119 | 2.1M | £104.7M | 6,919 | ||
| 120 | Methotrexate | Musculoskeletal and Joint Diseases | 2.1M | £23.5M | 6,575 |